Prime Medicine, Inc.
PRME · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$51 | -$53 | -$52 | -$42 |
| Dep. & Amort. | $2 | $1 | $2 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $6 | $6 | $0 |
| Change in WC | $1 | $1 | -$8 | $49 |
| Other Non-Cash | $13 | $3 | $3 | $8 |
| Operating Cash Flow | -$35 | -$41 | -$49 | $16 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$2 | -$2 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$134 | -$7 | -$48 | $17 |
| Inv. Sales/Matur. | $42 | $11 | $3 | $33 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$92 | $3 | -$48 | $48 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $6 | $0 |
| Stock Issued | $139 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $6 | $0 | $0 | $0 |
| Financing Cash Flow | $145 | $0 | $6 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $18 | -$38 | -$91 | $64 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $54 | $106 | $197 | $118 |
| End Cash | $71 | $67 | $106 | $182 |
| Free Cash Flow | -$35 | -$43 | -$51 | $14 |